Read More

80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial

Psychedelics biopharma company Mind Medicine Inc.’s (NASDAQ: MNMD) shared positive topline data from an advanced clinical trial evaluating its lysergide (aka LSD) for the treatment of Major Depressive Disorder (MDD) on Friday — just a couple of days before the 80th anniversary of the discov

MNMD

Read More

Clover Health Announces Business Transformation Initiatives To Accelerate Path To Profitability, Including An Agreement To Move Its Core Plan Operations To UST Healthproof’s Integrated Technology Platform And Additional Corporate Restructuring Actions

 Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover" or "Clover Health" or "the company"), today announced business transformation initiatives to accelerate the company's path

CLOV